MLYS - Mineralys Therapeutics, Inc.
28.43
1.190 4.186%
Share volume: 3,587,124
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$27.24
1.19
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-12-2024 | 02-12-2025 | 05-12-2025 | 11-10-2025 | |
| Assets | |||||||
| Total Assets | 347.249 M | 318.492 M | 268.253 M | 205.903 M | 354.941 M | 599.947 M | |
| Current Assets | 346.819 M | 318.001 M | 267.732 M | 205.351 M | 354.506 M | 599.796 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 248.147 M | 243.259 M | 166.329 M | 84.096 M | 178.019 M | 376.031 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 90.418 M | 67.856 M | 97.274 M | 114.091 M | 165.007 M | 217.597 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 51.000 K | 42.000 K | 69.000 K | 53.000 K | 38.000 K | 7.000 K | |
| Other Assets | 379.000 K | 449.000 K | 452.000 K | 499.000 K | 397.000 K | 144.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 347.249 M | 318.492 M | 268.253 M | 205.903 M | 354.941 M | 599.947 M | |
| Total liabilities | 19.204 M | 28.397 M | 31.321 M | 14.646 M | 13.386 M | 23.520 M | |
| Total current liabilities | 19.204 M | 28.397 M | 31.321 M | 14.646 M | 13.386 M | 23.520 M | |
| Accounts Payable | 4.261 M | 1.707 M | 3.106 M | 479.000 K | 373.000 K | 1.121 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 328.045 M | 290.095 M | 236.932 M | 191.257 M | 341.555 M | 576.427 M | |
| Common stock | 484.261 M | 487.325 M | 490.504 M | 493.775 M | 686.284 M | 1.001 B | |
| Retained earnings | -156.216 M | -197.230 M | -253.572 M | -302.518 M | -344.729 M | -424.935 M |